19 May 2020 - Document open to public comment until 9 June 2020.
The Institute for Clinical and Economic Review (ICER) has posted a Draft Scoping Document outlining a planned review of the comparative clinical effectiveness and value of supervised injection facilities.
To enable clinical experts and patient advocates to respond to the COVID-19 pandemic, ICER has expanded the timeframe for this assessment.